Northwestern Doc Says AbbVie's Androgel Has Heart Risks

Law360, Chicago (June 8, 2017, 7:32 PM EDT) -- A cardiologist who teaches at Northwestern University was called to the stand Thursday during the fourth day of a bellwether trial against AbbVie Inc. to testify about his belief that testosterone replacement medicines like Androgel increase the risk of heart attacks in older men.

Dr. Hossein Ardehali appeared as an expert witness on behalf of Jeffrey Konrad, a Tennessee man who blames his 2010 heart attack on the Androgel he began using two months before the event.

Konrad's case is the first to go before a jury of around 4,200 filed against AbbVie, the maker of the drug, and several thousand...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!